Rituximab induces phenotypical and functional changes of NK cells in a non-malignant experimental setting.
Wolfgang MerktHanns-Martin LorenzCarsten WatzlPublished in: Arthritis research & therapy (2016)
NK cells mediate rituximab-induced B cell depletion. Rituximab induces altered NK cell phenotype and function.